US Activist Hedge Fund Institutional SEC 13D 13G — September 18, 2026

18-09-2026

Mill Road Capital III, L.P. and related reporting persons filed Amendment No. 3 to Schedule 13D, disclosing beneficial ownership of 1,938,316 shares of Mistras Group, Inc. common stock, representing approximately 6.1% of outstanding shares. During the reporting period (July 20, 2026 to September 18, 2026), the fund purchased an additional 1,002 shares at $17.058 per share and sold multiple call and put options on the company's stock, including call options with a $25 strike price expiring February 2027 and put options with strike prices ranging from $15 to $17.50. The filing indicates active options trading alongside a modest open-market share purchase, but no material change in overall ownership percentage.

• · The fund sold call options on 9/16/2026 and 9/17/2026, each with a $25 strike price and expiration on 2/19/2027, receiving premiums of $1.0997 and $1.2105 per underlying share respectively.
• · Put options sold include multiple tranches with strike prices of $15 and $17.50, with expiration dates ranging from 9/18/2026 to 11/20/2026.
• · The purchase price of shares acquired via put option assignment is not reduced by premiums received from selling the put options.
• · No other contracts, arrangements, or understandings exist among the reporting persons or with third parties regarding the issuer's securities beyond those disclosed.

18-09-2026

Melco International Development Ltd, its wholly-owned subsidiary Melco Leisure and Entertainment Group Ltd, and Chairman/CEO Lawrence Ho filed an amended Schedule 13D disclosing a decrease in Mr. Ho's direct holdings due to a gift of Ordinary Shares to an irrevocable trust for generational wealth planning. The Reporting Persons continue to control a majority of Melco Resorts & Entertainment LTD, with Melco Leisure directly owning 687,360,906 Ordinary Shares (56.3% of the total). The filing also details a history of related-party transactions including share repurchases, a $1 billion credit facility, and an intercompany loan agreement.

• · The decrease in Mr. Ho's holdings was due to a gift of Ordinary Shares to an irrevocable, professionally-managed trust for generational wealth planning.
• · No transactions in the Issuer's Ordinary Shares were effected by the Reporting Persons during the past 60 days.
• · The Reporting Persons have significant influence and control over the Issuer, with three out of seven board members being current officers or board members of Melco International and Melco Leisure.
• · Melco Leisure's 687,360,906 Ordinary Shares are pledged as security for a $1 billion credit facility.
• · The Intercompany Loan Agreement was terminated after the August 2023 share repurchase.

18-09-2026

KKR Alternative Assets LLC and related entities filed Amendment No. 18 to their Schedule 13D, disclosing beneficial ownership of 9,866,525.787 Class I shares (29.4%) of KKR Real Estate Select Trust Inc. On September 16, 2026, KKR Alternative Assets LLC made an early contribution of 1,933,109 Support Shares under the Amended NAV Support Agreement, which are permanently cancelled. The NAV per Class I share as of the filing date was $23.26.

• · The filing is Amendment No. 18 to the Schedule 13D originally filed on August 26, 2021.
• · The early contribution of 1,933,109 Support Shares represents approximately one quarter of the total Support Shares under the Amended NAV Support Agreement.
• · KKR Alternative Assets LLC remains obligated to contribute on June 1, 2027 the aggregate number of Support Shares that would have been required without the early contributions.
• · NAV per Class I share as of the filing date is $23.26.
• · The reporting persons include a chain of entities from KKR Alternative Assets LLC up to KKR & Co. Inc., KKR Management LLP, and founders Henry R. Kravis and George R. Roberts.

18-09-2026

In Amendment No. 4 to Schedule 13D, Freedom Holding Corp.'s CEO and Chairman, Timur R. Turlov, disclosed a bona fide gift of 1,000,000 common shares to Askar Tashtitov on September 16, 2026. Following the transfer, Turlov beneficially owns 41,405,112 shares, representing approximately 64.91% of the outstanding common stock, with sole voting and dispositive power. No other purchases were made in the past 60 days, and no other arrangements regarding the securities were disclosed.

• · The gift was made as a bona fide gift, not a sale or purchase.
• · Turlov retains sole power to vote and dispose of all 41,405,112 shares.
• · No purchases of common stock were made by Turlov during the past 60 days.
• · The transfer was reported on September 18, 2026, with the transaction date of September 16, 2026.
• · The filing is Amendment No. 4 to the original Schedule 13D.

18-09-2026

Bess Ventures & Advisory, LLC and related parties (Lane Bess and the Destin Huang Irrevocable Trust) filed an amended Schedule 13D disclosing aggregate beneficial ownership of approximately 10.4% of Blaize Holdings, Inc. common stock, or 13,021,985 shares. The filing details a complex acquisition history involving the conversion of pre-merger Blaize shares, stock options, and a $25 million loan to the sponsor that led to a default, foreclosure on 3,500,000 shares, and a subsequent settlement agreement adding 2,000,000 shares. However, a third forbearance agreement has deferred beneficial ownership of an additional 2,000,000 shares of collateral stock, which remain with the sponsor until at least December 31, 2026.

• · The Business Combination closed on January 13, 2025, with pre-merger Blaize shares converting at a ratio of approximately 0.78 shares of Common Stock per share of Blaize common stock.
• · Bess Ventures loaned $25,000,000 to the sponsor to facilitate the Closing; the sponsor defaulted on the Bess Notes.
• · On May 8, 2026, 3,500,000 shares of Debtor Collateral Stock (including Sponsor Stock) were foreclosed upon.
• · On July 7, 2026, the Company issued 2,000,000 shares of Common Stock to Bess Ventures pursuant to a Settlement Agreement.
• · The Third Forbearance Agreement, dated September 16, 2026, defers beneficial ownership of 2,000,000 shares of Debtor Collateral Stock to the sponsor until the earlier of December 31, 2026 or a forbearance termination event.
• · Lane Bess serves as Chairman of the Board of Blaize Holdings.
• · The filing states the Reporting Persons may engage in discussions with the Board and management regarding extraordinary corporate transactions, changes in business strategy, capitalization, or board composition.

18-09-2026

Jane Street Group, LLC disclosed a 5.3% beneficial ownership stake in Maison Solutions Inc. (MSS) as of September 14, 2026, holding 42,744 shares of Class A Common Stock. The filing is made under Rule 13d-1(c) and certifies the securities were not acquired with the purpose of changing or influencing control of the issuer. The stake is held through subsidiaries Jane Street Capital, LLC (2.8%) and Jane Street Global Trading, LLC (2.4%), with no sole voting or dispositive power over any shares.

• · The filing is a Schedule 13G (not 13D), indicating passive investment intent.
• · Jane Street Group, LLC has shared voting power and shared dispositive power over all 42,744 shares.
• · Jane Street Capital, LLC holds 22,953 shares (2.8%) and Jane Street Global Trading, LLC holds 19,791 shares (2.4%).
• · The filing date is September 18, 2026, with the event date of September 14, 2026.

18-09-2026

The Trust Under Article 2 of The Zinterhofer 2008 Descendants Trust and Eric Louis Zinterhofer filed an amended Schedule 13D with the SEC, disclosing that as of September 16, 2026, the trust beneficially owns 4,910,594 shares of Class B Common Stock (convertible into Class A Common Stock), representing 1.9% of Class A shares and 3.5% of total voting power. Eric Louis Zinterhofer, a founding partner of Searchlight Capital Partners and a board member of Estée Lauder, was added as a reporting person and now holds an additional 2,780 shares via stock options. The filing also notes that Jane Lauder has stepped down as a trustee of the trust.

• · Jane Lauder no longer acts as trustee of the 2008 Descendants Trust.
• · Eric Louis Zinterhofer became a trustee on September 16, 2026, and became party to the Stockholders' Agreement.
• · The trust's 4,910,594 Class B shares carry 10 votes per share, giving it 3.5% voting power.
• · No transactions in Class A Common Stock were effected by the reporting persons during the past 60 days.
• · The Stockholders' Agreement includes a right of first offer on transfers of Class A shares to non-Lauder Family Members.

18-09-2026

Nilesh Undavia and related parties filed Amendment No. 3 to their Schedule 13D, disclosing beneficial ownership of 2,211,504 shares (8.5%) of GrafTech International Ltd. The group recently purchased additional shares in open-market transactions, including a large 225,784-share purchase by the Nilesh P Undavia 2018 Trust on September 16, 2026 at an average price of about $8.11 per share. The filing also notes a 1-for-10 reverse stock split effective August 29, 2025, which reduced the prior reported share count from 17,308,942 to 1,730,895 on a post-split basis.

• · A 1-for-10 reverse stock split was effected on August 29, 2025; all share figures in the amendment reflect the split.
• · The group's prior reported 17,308,942 shares (Amendment No. 2) correspond to 1,730,895 shares on a post-split basis.
• · The reporting persons have a verbal agreement to vote, hold, or sell shares in concert, forming a group under SEC Rule 13d-5.
• · Nilesh Undavia may be deemed to beneficially own 620,000 shares via Charles Schwab IRA and 402,474 shares via JP Morgan IRA.
• · Recent purchases include 225,784 shares by the Nilesh P Undavia 2018 Trust on Sep 16, 2026 at prices ranging from $7.36 to $8.11 per share.

18-09-2026

Linonia Partners Fund LP and related entities disclosed a 9.3% beneficial ownership stake in Liberty Live Holdings, Inc., representing 2,376,439 shares, following a split-off from Liberty Media on December 15, 2025. The filing, made on September 18, 2026, covers Linonia Partners Fund LP, The Linonia Partnership LP, The Linonia Partnership GP LLC, and Philip Uhde, all of whom share voting and dispositive power over the shares. The reporting persons disclaim beneficial ownership except to the extent of pecuniary interest.

• · The split-off was completed on December 15, 2025, with each outstanding Liberty Media Series A Liberty Live share redeemed for one Liberty Live share.
• · Prior to the split-off, the reporting persons owned 2,498,950 shares (approximately 9.8%) of Liberty Media's Series A Liberty Live common stock.
• · The filing is made pursuant to Rule 13d-1(c) and includes a joint filing statement under Rule 13d-1(k)(1).
• · The reporting persons disclaim beneficial ownership except to the extent of pecuniary interest.

18-09-2026

Alector, Inc. (ALEC) filed a Schedule 13G on September 18, 2026, disclosing that the Biotechnology Value Fund group, led by Mark N. Lampert, collectively beneficially owns 9,374,267 shares of Alector common stock, representing approximately 8.4% of the outstanding shares. The filing is a routine passive ownership disclosure under Rule 13d-1(c), with no indication of any intent to change or influence control of the company.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent with no control purpose.
• · The total outstanding shares used for percentage calculations is 111,656,919 as of July 31, 2026, per Alector's Form 10-Q filed on August 6, 2026.
• · A Joint Filing Agreement (Exhibit 99.1) was executed by all reporting persons on September 18, 2026.

18-09-2026

FR Capital Holdings, L.P. and affiliated funds (First Round Capital VI, L.P. and First Round Capital VIII-F, L.P.) filed an amended Schedule 13G disclosing aggregate beneficial ownership of 1,025,554 shares of Merlin, Inc. common stock, representing approximately 1.0% of shares outstanding. The filing reports an in-kind distribution of shares to partners on September 16, 2026, after which the remaining holdings consist of convertible preferred stock and warrants with a conversion/exercise price of $6.67 per share. The ownership percentage is very small (1.0%), indicating a passive, non-controlling stake.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c), indicating passive investment intent.
• · The reporting persons certify the securities were not acquired to change or influence control of the issuer.
• · The issuer changed its name from Inflection Point Acquisition Corp. IV to Merlin, Inc. on October 21, 2025, and from Bleichroeder Acquisition Corp. I on June 27, 2024.
• · The conversion/exercise price for both the preferred stock and warrants is $6.67 per share.
• · The in-kind distribution occurred on September 16, 2026, with no consideration received.

18-09-2026

Albert Wong, Chairman and CEO of Eastern International Ltd., filed an amended Schedule 13D disclosing his aggregate beneficial ownership of approximately 39.8% of the company's ordinary shares, including shares held through Eastern Worldwide Logistics Group Inc. (33.2%) and directly owned shares and preferred stock. On August 27, 2026, the company issued 200,000 Series B Preferred Shares to Wong for $200,000, each carrying 100 votes and convertible into ordinary shares. The filing shows increased insider control but no recent trading activity in ordinary shares.

• · Albert Wong is a 70% shareholder and director of Eastern Worldwide Logistics Group Inc., which holds 4,266,000 ordinary shares (33.2%).
• · Wong directly owns 180,000 ordinary shares, 1,000,000 Series A Preferred Shares, and 200,000 Series B Preferred Shares.
• · Each Series A Preferred Share has 10 votes; each Series B Preferred Share has 100 votes.
• · The Series B Preferred Shares were issued on August 27, 2026, at $1.00 per share for an aggregate of $200,000.
• · No transactions in ordinary shares were effected by the reporting persons during the past 60 days.

18-09-2026

Orca Capital AG filed a Schedule 13G/A with the SEC on September 18, 2026, disclosing beneficial ownership of 180,913 shares of Nuwellis, Inc. common stock, representing 4.9% of the outstanding shares as of September 17, 2026. The filing indicates that Orca Capital AG holds no other securities or derivative instruments, and its ownership is subject to a 4.99% blocker on warrant exercise. The stake is below the 5% threshold, suggesting a passive investment position.

• · The filing is an amendment (Schedule 13G/A) to a prior Schedule 13G.
• · Orca Capital AG's address is Sperlring 2, 85276 Hettenshausen, Germany.
• · The shares are held directly by Orca Capital AG with no shared voting or dispositive power.
• · The filing certifies the securities were not acquired to change or influence control of the issuer.

18-09-2026

Millennium Management LLC, together with Millennium Group Management LLC and Israel A. Englander, disclosed a 5.6% beneficial ownership stake in Lincoln International, Inc. as of September 14, 2026, holding 2,029,417 shares of Class A Common Stock. The filing was made under Rule 13d-1(c) and includes a joint filing agreement among the reporting entities. The stake is held for investment purposes and not with the intent to change or influence control of the issuer.

• · The filing is a Schedule 13G (not 13D), indicating passive investment intent.
• · The reporting persons disclaim beneficial ownership of the securities held by underlying entities, except to the extent of their pecuniary interest.
• · The joint filing agreement was executed on September 17, 2026.
• · The issuer's Class A Common Stock has a par value of $0.00001 per share.
• · The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.

18-09-2026

General Atlantic, L.P. and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 3,201,131 shares of Korsana Biosciences, Inc. (formerly Cyclerion Therapeutics, Inc.), representing 6.8% of the outstanding common stock as of September 8, 2026. The filing is a routine disclosure of a major shareholding position and does not indicate any change in control or corporate action.

• · The filing is made under Rule 13d-1(d) (passive investor exemption).
• · General Atlantic (KB), L.P. is the only entity holding shares of record (1,366,242 common shares + Pre-Funded Warrant for 1,834,889 shares).
• · The Pre-Funded Warrant includes a blocker provision preventing beneficial ownership exceeding 9.99% of outstanding common stock.
• · The company changed its name from Cyclerion Therapeutics, Inc. to Korsana Biosciences, Inc. effective October 4, 2018.
• · The Partnership Committee members disclaim beneficial ownership of the shares except to the extent of any pecuniary interest.

18-09-2026

JATT Ventures II L.P., the sponsor of JATT II Acquisition Corp., filed an amendment to its Schedule 13D to correct the citizenship of Someit Sidhu, who is the Chairman, Director, and CEO of the issuer. The sponsor beneficially owns 1,800,000 ordinary shares (23.10% of the outstanding shares as of June 30, 2026), including 300,000 ordinary shares and 1,500,000 founder shares, with no recent transactions in the prior 60 days. The filing also confirms the sponsor's agreement to vote in favor of a business combination and not to seek redemption rights, but no plans for additional acquisitions or material corporate changes are disclosed.

• · The Sponsor paid $25,000, or approximately $0.014 per share, for 1,725,000 Founder Shares on February 12, 2026.
• · 225,000 Founder Shares were forfeited subject to the expiration of the underwriters' over-allotment option.
• · The Sponsor agreed to vote all ordinary shares in favor of a proposed Business Combination and not to seek redemption rights.
• · The Sponsor has not effected any transactions in the Issuer's ordinary shares during the 60 days preceding the filing date.
• · The filing amends the original Schedule 13D to correct the citizenship of Someit Sidhu.

18-09-2026

Upender V. Rao filed a Schedule 13G/A with the SEC on September 18, 2026, disclosing beneficial ownership of 100,000 shares of Direxion Shares ETF Trust, representing an 11.0% stake. The filing indicates sole voting and dispositive power over all shares, and the securities were acquired in the ordinary course of business without intent to influence control.

• · Filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
• · Rao has sole voting power over 100,000 shares and sole dispositive power over 100,000 shares.
• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Rao's address is 305 East 63rd Street, Apt 15D, New York, NY 10065.
• · The trust's principal business address is 535 Madison Avenue, 37th Floor, New York, NY 10022.

18-09-2026

Thrive Capital entities, led by Joshua Kushner, filed an amended Schedule 13D on September 18, 2026, disclosing an aggregate beneficial ownership of 12.1% of Oscar Health, Inc.'s Class A Common Stock. The filing details a series of internal transfers and distributions among Thrive funds, including the transfer of Class B shares to Thrive VII Growth and Claremount VII in exchange for Class A shares, followed by pro rata distributions to limited partners. No material change in overall economic exposure or voting power was reported, as the transactions were internal reorganizations.

• · Thrive II transferred 1,307,831 Class B shares to Thrive VII Growth and 15,758 Class B shares to Claremount VII in exchange for Class A shares.
• · Thrive III transferred 4,798,003 Class B shares to Thrive VII Growth and 57,807 Class B shares to Claremount VII in exchange for Class A shares.
• · Claremount TW transferred 162,263 Class B shares to Thrive VII Growth and 1,955 Class B shares to Claremount VII in exchange for Class A shares.
• · Following the exchanges, Thrive II distributed 1,323,589 Class A shares to its limited partners and general partner pro rata without consideration.
• · Thrive III distributed 4,855,810 Class A shares to its limited partners and general partner pro rata without consideration.
• · Claremount TW distributed 164,218 Class A shares to its limited partners and general partner pro rata without consideration.
• · No other transactions in Class A Common Stock were effected by the reporting persons in the last 60 days.

18-09-2026

Gregory Castaldo filed a Schedule 13G with the SEC on September 18, 2026, disclosing beneficial ownership of 548,365 shares of Creatd, Inc. common stock, representing a 9.61% stake. The filing indicates Castaldo holds sole voting and dispositive power over all shares, and the securities were not acquired with the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating the filer is a passive investor.
• · Castaldo's beneficial ownership includes 175,465 shares with sole voting and dispositive power and 372,900 shares with shared voting and dispositive power.
• · The issuer's total outstanding shares were verified at 5,706,230 as of September 17, 2026.
• · Castaldo is a U.S. citizen and his address is in Garnet Valley, PA.

18-09-2026

Cornelius B. Prior, Jr., a major shareholder of ATN International, Inc., filed an amended Schedule 13D disclosing a planned $5 million charitable gift to Harvard University's Salata Institute for Climate and Sustainability, to be fulfilled in 16 monthly installments through March 2028. The gift is being satisfied with shares of Common Stock, with 12,000 shares transferred on August 10, 2026 and 12,500 shares on September 4, 2026. Additionally, entities controlled by Mr. Prior (VI E-Cell Tropical Telecom Ltd. and the Prior Family Foundation) sold a combined 81,262 shares between June 25 and September 3, 2026, and expect to sell another 25,174 shares before year-end 2026, reducing his beneficial ownership to 28.19% of the company's outstanding shares.

• · The planned gift of $5M will be fulfilled in 16 installments: eight of $375,000 (Aug 2026–Mar 2027) and eight of $250,000 (Aug 2027–Mar 2028).
• · Mr. Prior disclaims beneficial ownership of shares held by VI E-Cell (except pecuniary interest), his wife, and the Prior Family Foundation.
• · VI E-Cell sold shares at prices ranging from $27.05 to $33.25 per share during the reporting period.
• · The filing does not disclose any change in Mr. Prior's plans or intentions regarding control of the company.

18-09-2026

Brown Brothers Harriman & Co and its affiliate Brown Brothers Hriman Credit Partners, LLC filed an amended Schedule 13D/A, reporting aggregate beneficial ownership of 3,023,437.11 Class S Units of AMG BBH Asset-Backed Credit Fund, LLC, representing 66.23% of the class. The filing discloses recent open-market purchases of 293,938.50 Class S Units at approximately $11.28-$11.29 per share between September 15-17, 2026, funded by client accounts. The reporting persons' ownership remains dominant, but the amendment reflects only incremental acquisitions and no change in control.

• · The reporting persons acquired 121,010.64 units on 9/15/2026, 85,549.65 units on 9/16/2026, and 87,378.21 units on 9/17/2026, all at approximately $11.28-$11.29 per share.
• · The filing states that no other transactions occurred in the 60 days prior to the amendment other than those listed in Exhibit 99.2.
• · The original Schedule 13D was filed on July 14, 2026, and the joint filing agreement is dated July 14, 2026.
• · The issuer's name changed from AMG BBH Asset-Backed Fund, LLC to AMG BBH Asset-Backed Credit Fund, LLC on November 19, 2025.

18-09-2026

JMD CORPORATE SERVICES LIMITED filed a Schedule 13D disclosing beneficial ownership of 18,000,000 ordinary shares of Troops, Inc. (TROO), representing 14.70% of the outstanding shares. The shares were acquired from Prime Ocean Holding Limited on March 11, 2026, for a total consideration of US$16,680,000. The filing indicates JMD may seek to influence management or the board, but no specific plans for major corporate actions are currently disclosed.

• · The shares were acquired on March 11, 2026, via a share transfer agreement with Prime Ocean Holding Limited.
• · Each ordinary share has a par value of US$0.004.
• · JMD CORPORATE SERVICES LIMITED is incorporated in Hong Kong with limited liability.
• · The Reporting Person has sole voting and dispositive power over all 18,000,000 shares.
• · No transactions in Troops securities were conducted by the Reporting Person in the 60 days prior to the filing date (September 18, 2026).
• · The filing states that JMD may review and change its position and may seek to influence management or the board, but no specific plans under Item 4 (a)-(j) are currently in place.

18-09-2026

Amit Mohan Agarwal filed a Schedule 13G/A with the SEC on September 18, 2026, disclosing beneficial ownership of 2,400,000 shares of biote Corp. (BTMD), representing 8.37% of the company's outstanding common stock. The filing indicates that Mr. Agarwal holds sole voting and dispositive power over all shares, and certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c).
• · Amit Agarwal's address is PO Box 18861, Tampa, FL 33679.
• · The filing date is September 18, 2026, with an event date of September 10, 2026.
• · The company's former name was Haymaker Acquisition Corp. III, changed on July 27, 2020.

18-09-2026

Johannes Gnauck and JG Global LLC filed a Schedule 13G with the SEC on September 18, 2026, disclosing beneficial ownership of 2,377,408 shares of Microvision, Inc. common stock, representing 7.9% of the 30,150,027 shares outstanding as of August 14, 2026. The filing indicates passive investment intent under Rule 13d-1(c), with no purpose or effect of changing or influencing control of the issuer.

• · Filing made under Rule 13d-1(c) indicating passive investment intent.
• · Johannes Gnauck is a United States citizen; JG Global LLC is formed in Wyoming.
• · Reporting Persons disclaim any purpose of changing or influencing control of Microvision.
• · Gnauck has the right to receive dividends and proceeds from the sale of the reported shares.

18-09-2026

MJL Manager LLC and Michael Liu filed a Schedule 13G with the SEC on September 18, 2026, disclosing beneficial ownership of Xenetic Biosciences, Inc. common stock. The filing reports 0% beneficial ownership for both reporting persons, indicating no current reportable stake, and includes a joint filing statement. The filing is a routine regulatory disclosure under Rule 13d-1(c).

• · Filing date: September 18, 2026
• · Subject company: Xenetic Biosciences, Inc. (CIK 0001534525), incorporated in NV, fiscal year end 1231
• · Reporting persons: MJL Manager LLC (CIK 0002103370) and Michael Liu
• · Security: Common Stock, $0.001 par value per share
• · CUSIP: 984015602
• · Rule 13d-1(c) filing
• · Both reporting persons disclaim beneficial ownership except for pecuniary interest

18-09-2026

Michael John O'Connor and his wholly controlled entity Larchwood Management Partners Inc. filed a belated Schedule 13D disclosing combined beneficial ownership of 16,055,992 shares (16.0%) of Rainmaker Worldwide Inc. as of September 18, 2026. The filing details a series of transactions since January 2025, including the conversion of $529,859.63 in indebtedness into 15,269,730 shares, a subsequent transfer of 16,518,432 shares from Larchwood to O'Connor personally, and the issuance of a new $137,301.99 convertible note to Larchwood. O'Connor resigned as CEO and director of Rainmaker in September 2026, and the filing notes that a proposed sale of 837,997 shares was not consummated.

• · The Schedule 13D was filed after the applicable deadline; initial filing obligation arose on January 2, 2025.
• · O'Connor resigned as CEO and director of Rainmaker in September 2026.
• · No transactions in Common Stock were effected by either Reporting Person during the 60 days preceding September 18, 2026.
• · The convertible note matures on December 31, 2026 and carries a fixed conversion price of $0.027 per share.
• · Larchwood ceased to be a >5% beneficial owner on July 17, 2025 but regained >5% status on December 31, 2025 upon issuance of the convertible note.

18-09-2026

Anthony Brian Goodman, through his ownership of Luxor Capital, LLC, filed an amendment to Schedule 13D disclosing open-market sales of Golden Matrix Group, Inc. (now Meridian Holdings Inc./NV) common stock. Between July 20, 2026 and September 17, 2026, Goodman sold a total of 290,873 shares, reducing his beneficial ownership to approximately 2.30% of the 12,669,479 shares outstanding as of July 29, 2026. The sales were executed at prices ranging from $13.03 to $14.38 per share, reflecting a mix of small and medium-sized trades, with no indication of a full exit.

• · Sales occurred from July 20, 2026 through September 17, 2026, with individual trades ranging from 500 to 20,000 shares.
• · Sale prices ranged from $13.03 to $14.38 per share.
• · Goodman's aggregate beneficial ownership after the sales is 290,873 shares, representing approximately 2.30% of the class.
• · The filing is an amendment to Schedule 13D, not an exit filing; Goodman continues to own more than 5% on a different reconciliation basis.
• · Luxor Capital, LLC is a Nevada limited liability company that develops and owns intellectual property.
• · The reporting persons have not been involved in any securities-related legal proceedings in the last five years.